Clinical Trial Update: Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population [Phase 4]

View source ↗

Summary

Phase 4 trial updating on low-dose Celebrex with aspirin assessing incidence of gastroduodenal ulcers in a healthy population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcers

Drugs mentioned

• Acetylsalicylic acid (aspirin) (aspirin)
• CELEBREX (Celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Peptic Ulcers | Phase 4 | Status: COMPLETED